Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation.

Brunet J, Pfaff AW, Abidi A, Unoki M, Nakamura Y, Guinard M, Klein JP, Candolfi E, Mousli M.

Cell Microbiol. 2008 Apr;10(4):908-20. Epub 2007 Nov 14.

PMID:
18005238
2.

Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.

Gao Y, Lin LP, Zhu CH, Chen Y, Hou YT, Ding J.

Cancer Biol Ther. 2006 Aug;5(8):978-85. Epub 2006 Aug 3.

PMID:
16855382
3.

Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.

Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, Ishikawa H, Saya H.

Genes Cells. 2004 Feb;9(2):131-42.

4.

Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.

Nomura N, Nomura M, Newcomb EW, Zagzag D.

Biochem Pharmacol. 2007 May 15;73(10):1528-36. Epub 2007 Jan 21.

PMID:
17324379
5.

Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells.

Dagon Y, Dovrat S, Vilchik S, Hacohen D, Shlomo G, Sredni B, Salzberg S, Nir U.

Oncogene. 2001 Dec 6;20(56):8045-56.

6.

Helicobacter pylori inhibits activity of cdc2 kinase and delays G2/M to G1 progression in gastric adenocarcinoma cell line.

Chiou CC, Chan CC, Kuo YP, Chan EC.

Scand J Gastroenterol. 2003 Feb;38(2):147-52.

PMID:
12678330
7.

Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.

Minemoto Y, Gannon J, Masutani M, Nakagama H, Sasagawa T, Inoue M, Masamune Y, Yamashita K.

Exp Cell Res. 2001 Jan 1;262(1):37-48.

PMID:
11120603
8.

Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.

Qiao M, Shapiro P, Fosbrink M, Rus H, Kumar R, Passaniti A.

J Biol Chem. 2006 Mar 17;281(11):7118-28. Epub 2006 Jan 9.

9.
10.

Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.

Chiu SJ, Lee YJ, Hsu TS, Chen WS.

Chem Biol Interact. 2009 Dec 10;182(2-3):173-82. doi: 10.1016/j.cbi.2009.08.019. Epub 2009 Sep 6.

PMID:
19735649
11.

Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.

Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY.

Cancer Res. 2000 Feb 1;60(3):542-5.

12.
13.
14.

Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells.

Wong SH, Shih RS, Schoene NW, Lei KY.

Am J Physiol Cell Physiol. 2008 Jun;294(6):C1342-9. doi: 10.1152/ajpcell.00061.2008. Epub 2008 Mar 19.

15.

Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.

Song JD, Kim KM, Kim KH, Kim CD, Kim JM, Yoo YH, Park YC.

Int J Oncol. 2008 Dec;33(6):1299-306.

PMID:
19020764
16.

Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.

Unoki M, Brunet J, Mousli M.

Biochem Pharmacol. 2009 Nov 15;78(10):1279-88. doi: 10.1016/j.bcp.2009.05.035. Epub 2009 Jun 6. Review.

PMID:
19501055
17.

Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.

Moh MC, Zhang T, Lee LH, Shen S.

Carcinogenesis. 2008 Dec;29(12):2298-305. doi: 10.1093/carcin/bgn226. Epub 2008 Oct 8.

PMID:
18845560
18.

Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1.

Spaziani A, Alisi A, Sanna D, Balsano C.

J Biol Chem. 2006 Apr 21;281(16):10983-9. Epub 2006 Jan 30.

19.

Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.

Cerquetti L, Bucci B, Marchese R, Misiti S, De Paula U, Miceli R, Muleti A, Amendola D, Piergrossi P, Brunetti E, Toscano V, Stigliano A.

Endocr Relat Cancer. 2008 Jun;15(2):623-34. doi: 10.1677/erc.1.1315.

20.

Radiation and the G2 phase of the cell cycle.

Hwang A, Muschel RJ.

Radiat Res. 1998 Nov;150(5 Suppl):S52-9. Review.

PMID:
9806609

Supplemental Content

Support Center